The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> October 5, 2018

Interview with the President, CEO and Director: Interpace Diagnostics Group, Inc. (NASDAQ:IDXG)

Stover, Jack E.
Jack E. Stover is President, Chief Executive Officer and Director of Interpace Diagnostics Group, Inc. Mr. Stover has been the Chief Executive Officer and President of Interpace Diagnostics Group, Inc., since December of 2015. Mr. Stover has also been a director and Chairman of the audit committee of Onconova Therapeutics, Inc., since May of 2016. He also previously served as President, CEO and Director of Antares Pharma Inc. from September 1, 2004, to October 2008. Mr. Stover also previously served as Executive Vice President, Chief Financial Officer and Treasurer of SICOR Inc. from April 2002 to August 12, 2003. Prior to joining Sicor Inc., Mr. Stover served as Executive Vice President and Director of a proprietary women's drug company, Gynetics Inc., and Senior Vice President, Chief Information Officer and Chief Financial Officer of B. Braun of America. From 1975 to 1993, he was employed by PricewaterhouseCoopers LLP — formerly, Coopers & Lybrand — where, since 1985, he was a partner. Mr. Stover holds a bachelor’s degree in accounting and business from Lehigh University and is a certified public accountant. Profile
Word count: 4,148

TWST: Interpace Diagnostics is a molecular diagnostic provider, but can you summarize the underlying technology and your lead commercial offerings?

Mr.

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc
CEO INTERVIEWS
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
Interview with the Co-CEO and the CAO: Planet 13 Holdings Inc. (OTCMKTS:PLNH)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Profitability Strategy Pays Off for Bank IT Company Q2 Holdings
Three Mid-Cap Names Using Their Balance Sheets to Create Value
Look Beyond Traditional Emerging Markets for More Diversification, Less Risk
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy